Molecularly targeted approaches to the chemoprevention of lung cancer

Clinical Cancer Research

Volumn 10, Issue 12 II, 2004, Pages

  Khuri, Fadlo R ^a   Cohen, Victor ^b  

^a EMORY UNIVERSITY   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALITRETINOIN; ALPHA PENTYL 3 (2 QUINOLYLMETHOXY)BENZYL ALCOHOL; ALPHA TOCOPHEROL; ARACHIDONATE 5 LIPOXYGENASE; ATRELEUTON; BETA CAROTENE; CELECOXIB; CYANOCOBALAMIN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; ETRETINATE; FENRETINIDE; FOLIC ACID; GEFITINIB; ISOTRETINOIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PLACEBO; PROTEIN BCL 2; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; RAS PROTEIN; RETINOIC ACID RECEPTOR BETA; RETINOID; RETINOL; RETINOL PALMITATE; TIPIFARNIB; UNINDEXED DRUG;

CANCER PREVENTION; CANCER SURVIVAL; CHEMOPROPHYLAXIS; CIGARETTE SMOKING; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TARGETING; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; METAPLASIA; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; SPUTUM ANALYSIS;

CHEMOPREVENTION; DISEASE PROGRESSION; ENZYME INHIBITORS; HUMANS; LUNG NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, RETINOIC ACID; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 3042668237     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-040019     Document Type: Conference Paper

References (27)

1. Lung cancer. In: Stewart BW, Kleihues P, editors. World cancer report, Lyon, France: IARC Press; 2003. p 182-7.
2. Ginsberg RI, Vokes EE, Rosenzweig K. Cancer of the lung. Non-small-cell lung cancer. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology, 6th ed. Philadelphia: Lippincott-Raven; 2001, p. 925-83.
3. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
4. Sporn MB, Dunlop NM, Newton DI, Smith JM. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc 1976;35:1332-8.
5. Hong W, Endicott J, Itri, LM, et al. 13-cis-retinoic acid in the treatment of oral leukoplakia, N Engl J Med 1986;315:1501-5.
6. Hong WK, Lippman SM, Itri LM, et al. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N Engl J Med 1990;323:795-801.
7. Mao L, Lee JS, Kurie JM, et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst (Bethesda) 1997;89: 857-62.
8. Wistuba II, Lam S, Behrens C, et al. Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst (Bethesda) 1997;89:1366-73.
9. Auerbach O, Stout AP, Hammond ED, et al. Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. N Engl J Med 1961;265:253-67.
10. Schottenfield D. Epidemiology of lung cancer. In: Pass HI, Mitchell JB, Johnson DH, Turrisi AT, editors. Lung cancer principles and practice. Philadelphia: Lippincott-Raven; 1996. p. 305-21.
11. Mavne ST, Lippman SM. Retinoids, carotenoids and micronutrients. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology, 6th ed. Philadelphia: Lippincott-Raven; 2001. p. 575-90.
12. Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330: 1029-35.
13. Omenn GS, Goodman GE, Thomquist MD, et al. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5.
14. Hennekens CH, Bring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334: 1145-9.
15. Lee JS, Lippman SM, Benner SE, et al. Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous neoplasia. J Clin Oncol 1994;12:937-45.
16. Kurie JM, Lee JS, Khuri FR, et al. N-(4-Hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium. Clin Cancer Res 2000;6:2973-9.
17. Arnold AM, Browman GP, Levine MN, et al. The effect of the synthetic retinoid etretinate on sputum cytology: results from a randomised trial. Br J Cancer 1992;65:737-43.
18. McLarty JW, Holiday DB, Girard WM, Yanagihara RH, Kummet TD, Greenberg SD. Beta-carotene, vitamin A, and lung cancer chemoprevention: results of an intermediate endpoint study. Am J Clin Nutr 1995;62:1431S-8S.
19. Heimburger DC, Alexander CB, Birch R, Butterworth CE Jr, Bailey WC, Krumdieck CL. Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized double-blind intervention trial. J Am Med Assoc 1988;259: 1525-30.
20. Kurie JM, Lotan R, Lee JS, et al. Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trial [see comment]. J Natl Cancer Inst (Bethesda) 2003;95: 206-14.
21. Pastorino U, Infante M, Maioli M, et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 1993;11:1216-22.
22. van Zandwijk N, Dalesio O, Pastorino U, de Vries N, van Tinteren H. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the European Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups. J Natl Cancer Inst (Bethesda) 2000; 92:977-86.
23. Lippman SM, Lee JJ, Karp DD, et al. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst (Bethesda) 2001;93: 605-18.
24. Khuri FR, Lotan R, Kemp B, et al. Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer. J Clin Oncol 2000;18:2798-804.
25. Khuri FR, Wu H, Lee JJ, et al. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin Cancer Res 2001;7:861-7.
26. Hong WK, Spitz MR, Lippman SM. Cancer chemoprevention in the 21st century: Genetics, risk modeling and molecular targets. J Clin Oncol 2000;18:9s-18s.
27. Cohen V, Khuri FR. Chemoprevention of lung cancer: current status and future prospects. Cancer Metastasis Rev 2002;21:349-62.